XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Balance (in shares) at Dec. 31, 2017   10,829,918    
Beginning balance at Dec. 31, 2017 $ 181,321 $ 61,855 $ 121,144 $ (1,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 23,536   23,536  
Net unrealized loss on securities available for sale, net of tax (2,150)     (2,150)
Net loss on cash flow hedging derivative instruments (106)     (106)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax (23)     (23)
Unrecognized gain (loss) for post-retirement benefits, net of tax 184     184
Comprehensive income 21,441   23,536 (2,095)
Cash dividends declared (12,052)   (12,052)  
Equity compensation expense 381 $ 381    
Payment for repurchase of common stock (in shares)   (5,725)    
Payment for repurchase of common stock (168)   (168)  
Reclassification adjustment for effect of enacted tax law changes 0      
Issuance of restricted stock (in shares)   16,795    
Issuance of restricted stock 0      
Proceeds from sale of common stock (in shares)   21,663    
Proceeds from sale of common stock 619 $ 619    
Balance (in shares) at Dec. 31, 2018   10,862,651    
Ending balance at Dec. 31, 2018 191,542 $ 62,855 132,460 (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,156      
Net unrealized loss on securities available for sale, net of tax 3,512      
Net loss on cash flow hedging derivative instruments (465)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 3      
Ending balance at Mar. 31, 2019 197,787      
Balance (in shares) at Dec. 31, 2018   10,862,651    
Beginning balance at Dec. 31, 2018 191,542 $ 62,855 132,460 (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 25,525   25,525  
Net unrealized loss on securities available for sale, net of tax 8,708     8,708
Net loss on cash flow hedging derivative instruments (1,341)     (1,341)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 15     15
Unrecognized gain (loss) for post-retirement benefits, net of tax (13)     (13)
Comprehensive income 32,894   25,525 7,369
Cash dividends declared (12,963)   (12,963)  
Equity compensation expense 565 $ 565    
Payment for repurchase of common stock (in shares)   (7,178)    
Payment for repurchase of common stock (183)   (183)  
Issuance of restricted stock (in shares)   19,087    
Issuance of restricted stock 0      
Proceeds from sale of common stock (in shares)   24,650    
Proceeds from sale of common stock $ 653 $ 653    
Balance (in shares) at Dec. 31, 2019 10,899,210 10,899,210    
Ending balance at Dec. 31, 2019 $ 212,508 $ 64,073 144,839 3,596
Beginning balance at Mar. 31, 2019 197,787      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,395      
Net unrealized loss on securities available for sale, net of tax 4,289      
Net loss on cash flow hedging derivative instruments (898)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 4      
Ending balance at Jun. 30, 2019 204,593      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,288      
Net unrealized loss on securities available for sale, net of tax 936      
Net loss on cash flow hedging derivative instruments (340)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 1      
Ending balance at Sep. 30, 2019 208,489      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,686      
Net unrealized loss on securities available for sale, net of tax (29)      
Net loss on cash flow hedging derivative instruments 362      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 7      
Balance (in shares) at Dec. 31, 2019 10,899,210 10,899,210    
Ending balance at Dec. 31, 2019 $ 212,508 $ 64,073 144,839 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,495      
Net unrealized loss on securities available for sale, net of tax 4,233      
Net loss on cash flow hedging derivative instruments (4,870)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 8      
Ending balance at Mar. 31, 2020 $ 215,257      
Balance (in shares) at Dec. 31, 2019 10,899,210 10,899,210    
Beginning balance at Dec. 31, 2019 $ 212,508 $ 64,073 144,839 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 27,129   27,129  
Net unrealized loss on securities available for sale, net of tax 1,352     1,352
Net loss on cash flow hedging derivative instruments (5,029)     (5,029)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 49     49
Unrecognized gain (loss) for post-retirement benefits, net of tax 4     4
Comprehensive income 23,505   27,129 (3,624)
Cash dividends declared (13,453)   (13,453)  
Equity compensation expense 652 $ 652    
Payment for repurchase of common stock (in shares)   (5,447)    
Payment for repurchase of common stock (156)   (156)  
Issuance of restricted stock (in shares)   27,345    
Issuance of restricted stock 0      
Proceeds from sale of common stock (in shares)   29,181    
Proceeds from sale of common stock $ 670 $ 670    
Balance (in shares) at Dec. 31, 2020 10,950,289 10,950,289    
Ending balance at Dec. 31, 2020 $ 223,726 $ 65,395 158,359 (28)
Beginning balance at Mar. 31, 2020 215,257      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,569      
Net unrealized loss on securities available for sale, net of tax (790)      
Net loss on cash flow hedging derivative instruments (1,414)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 28      
Ending balance at Jun. 30, 2020 216,584      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 7,095      
Net unrealized loss on securities available for sale, net of tax (1,580)      
Net loss on cash flow hedging derivative instruments 387      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 7      
Ending balance at Sep. 30, 2020 219,440      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,970      
Net unrealized loss on securities available for sale, net of tax (511)      
Net loss on cash flow hedging derivative instruments 868      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 6      
Balance (in shares) at Dec. 31, 2020 10,950,289 10,950,289    
Ending balance at Dec. 31, 2020 $ 223,726 $ 65,395 $ 158,359 $ (28)